TAM HIF-2α likely limits excessive angiogenesis in multiple models as HIF-2α inhibition or myeloid HIF-2α deficiency increase microvessel density and increase tumor growth in lung and breast tumors [9,97]. Here, EPAS1 is linked to breast neoplasm.